Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-5,400
Closed -$281K 550
2016
Q1
$281K Hold
5,400
0.05% 366
2015
Q4
$254K Sell
5,400
-58
-1% -$2.87K 0.05% 394
2015
Q3
$263K Hold
5,458
0.05% 397
2015
Q2
$270K Sell
5,458
-20
-0.4% -$1.06K 0.04% 413
2015
Q1
$299K Sell
5,478
-520
-9% -$28.7K 0.05% 385
2014
Q4
$334K Buy
5,998
+540
+10% +$29.4K 0.06% 357
2014
Q3
$288K Buy
5,458
+46
+0.8% +$2.37K 0.05% 385
2014
Q2
$283K Buy
5,412
+12
+0.2% +$596 0.05% 394
2014
Q1
$261K Buy
+5,400
New +$251K 0.07% 300

Other funds holding SRE

Moors & Cabot's SRE Position: Q2 2016 in Review

Moors & Cabot sold out of Sempra (SRE) in Q2 2016, closing a stake of 5,400 shares — an estimated $281K sold.

Moors & Cabot first reported a position in SRE in Q1 2014 and held it in 9 quarters. The position peaked at $334K in Q4 2014. 594 funds tracked by Wall St. Rank hold SRE as of Q2 2016.

  • Moors & Cabot reported no remaining Sempra position as of Q2 2016 after selling out during the quarter.
  • Moors & Cabot sold 5,400 Sempra shares in Q2 2016, an estimated $281K.
  • Moors & Cabot first reported a position in Sempra in Q1 2014 and held it in 9 quarters.
  • Moors & Cabot's Sempra position peaked at $334K in Q4 2014.
  • 594 funds tracked by Wall St. Rank held Sempra as of Q2 2016.

Based on Moors & Cabot's 13F filing for Q2 2016, filed 8 Aug 2016.